A Study of Roginolisib in Combination With Ruxolitinib in Patients With Myelofibrosis (MF) Who Are Unresponsive to JAK Inhibitors

NCT06887803 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
26
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

iOnctura